|
ZBTB43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.268500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.241600E-01 |
| Normal-vs-Stage2 |
1.403390E-01 |
| Normal-vs-Stage3 |
3.837900E-02 |
| Normal-vs-Stage4 |
3.126300E-02 |
| Stage1-vs-Stage2 |
4.495800E-01 |
| Stage1-vs-Stage3 |
1.625190E-01 |
| Stage1-vs-Stage4 |
2.051200E-01 |
| Stage2-vs-Stage3 |
8.204600E-01 |
| Stage2-vs-Stage4 |
7.346200E-01 |
| Stage3-vs-Stage4 |
8.725600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.116000E-02 |
| Normal-vs-AfricanAmerican |
4.275200E-01 |
| Normal-vs-Asian |
9.665200E-01 |
| Caucasian-vs-AfricanAmerican |
7.584000E-01 |
| Caucasian-vs-Asian |
1.095780E-01 |
| AfricanAmerican-vs-Asian |
4.855000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.276400E-02 |
| Normal-vs-Female |
1.422830E-01 |
| Male-vs-Female |
4.107400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.552800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.051900E-02 |
| Normal-vs-Age(61-80Yrs) |
6.836500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.595000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.646420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.177860E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.094200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.622790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.079000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.810800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.565200E-01 |
| Classical-VS-Follicular |
3.57979999976443E-07 |
| Classical-VS-Other |
5.427900E-02 |
| Classical-VS-Normal |
6.838600E-01 |
| Tall-VS-Follicular |
2.368100E-02 |
| Tall-VS-Other |
4.033600E-01 |
| Tall-VS-Normal |
2.442000E-01 |
| Follicular-VS-Other |
2.072000E-01 |
| Follicular-VS-Normal |
4.34440000000036E-05 |
| Other-VS-Normal |
4.666400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.351730E-02 |
| Normal-vs-N1 |
3.609000E-01 |
| N0-vs-N1 |
1.942230E-01 |
|
|
